▶ 調査レポート

世界の注射用ゲムシタビン粉末市場インサイト・予測(~2027年)

• 英文タイトル:Global Gemcitabine Powder For Injection Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界の注射用ゲムシタビン粉末市場インサイト・予測(~2027年) / Global Gemcitabine Powder For Injection Market Insights and Forecast to 2027 / QY2112A05564資料のイメージです。• レポートコード:QY2112A05564
• 出版社/出版日:QYResearch / 2021年11月
• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥646,800 (USD4,900)▷ お問い合わせ
  Multi User¥970,200 (USD7,350)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は注射用ゲムシタビン粉末の世界市場の現状について調査・分析し、2027年までの市場を予測しました。注射用ゲムシタビン粉末の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(200mg、1g、2g)、用途別市場規模(成人用、小児用、老人用)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・注射用ゲムシタビン粉末の世界市場概要
・メーカー別の競争状況、市場シェア
・注射用ゲムシタビン粉末の種類別市場規模:200mg、1g、2g
・注射用ゲムシタビン粉末の用途別市場規模:成人用、小児用、老人用
・北米の注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの注射用ゲムシタビン粉末市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Accord Healthcare、Pfizer、Eli Lilly and Company、DRUG INTERNATIONAL LTD、Strides Pharma Science Limited、Getwell Pharmaceuticals、Jiangsu Hansoh Pharmaceutical Group、Harbin Pharmaceutical Group
・注射用ゲムシタビン粉末のバリューチェーン・販売チャネル分析
・注射用ゲムシタビン粉末の世界市場動向

Gemcitabine Powder For Injection is used alone or with other treatments/medications to treat certain types of cancer (including breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

Market Analysis and Insights: Global Gemcitabine Powder For Injection Market
The global Gemcitabine Powder For Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Gemcitabine Powder For Injection Scope and Segment
Gemcitabine Powder For Injection market is segmented by Dosage Type, and by Application. Players, stakeholders, and other participants in the global Gemcitabine Powder For Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Dosage Type and by Application for the period 2016-2027.

Segment by Dosage Type
200 mg
1 g
2 g

Segment by Application
Adult Use
Pediatric Use
Geriatric Use

By Company
Accord Healthcare
Pfizer
Eli Lilly and Company
DRUG INTERNATIONAL LTD
Strides Pharma Science Limited
Getwell Pharmaceuticals
Jiangsu Hansoh Pharmaceutical Group
Harbin Pharmaceutical Group

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Gemcitabine Powder For Injection Product Introduction
1.2 Market by Dosage Type
1.2.1 Global Gemcitabine Powder For Injection Market Size Growth Rate by Dosage Type
1.2.2 200 mg
1.2.3 1 g
1.2.4 2 g
1.3 Market by Application
1.3.1 Global Gemcitabine Powder For Injection Market Size Growth Rate by Application
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Gemcitabine Powder For Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Gemcitabine Powder For Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Gemcitabine Powder For Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Gemcitabine Powder For Injection Regions by Sales
2.4.1 Global Top Gemcitabine Powder For Injection Regions by Sales (2016-2021)
2.4.2 Global Top Gemcitabine Powder For Injection Regions by Sales (2022-2027)
2.5 Global Top Gemcitabine Powder For Injection Regions by Revenue
2.5.1 Global Top Gemcitabine Powder For Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Gemcitabine Powder For Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Gemcitabine Powder For Injection Sales by Manufacturers
3.1.1 Global Top Gemcitabine Powder For Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Gemcitabine Powder For Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Gemcitabine Powder For Injection Sales in 2020
3.2 Global Gemcitabine Powder For Injection Revenue by Manufacturers
3.2.1 Global Top Gemcitabine Powder For Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Gemcitabine Powder For Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Gemcitabine Powder For Injection Revenue in 2020
3.3 Global Gemcitabine Powder For Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gemcitabine Powder For Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gemcitabine Powder For Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Gemcitabine Powder For Injection Sales by Dosage Type
4.1.1 Global Gemcitabine Powder For Injection Historical Sales by Dosage Type (2016-2021)
4.1.2 Global Gemcitabine Powder For Injection Forecasted Sales by Dosage Type (2022-2027)
4.1.3 Global Gemcitabine Powder For Injection Sales Market Share by Dosage Type (2016-2027)
4.2 Global Gemcitabine Powder For Injection Revenue by Dosage Type
4.2.1 Global Gemcitabine Powder For Injection Historical Revenue by Dosage Type (2016-2021)
4.2.2 Global Gemcitabine Powder For Injection Forecasted Revenue by Dosage Type (2022-2027)
4.2.3 Global Gemcitabine Powder For Injection Revenue Market Share by Dosage Type (2016-2027)
4.3 Global Gemcitabine Powder For Injection Price by Dosage Type
4.3.1 Global Gemcitabine Powder For Injection Price by Dosage Type (2016-2021)
4.3.2 Global Gemcitabine Powder For Injection Price Forecast by Dosage Type (2022-2027)

5 Market Size by Application
5.1 Global Gemcitabine Powder For Injection Sales by Application
5.1.1 Global Gemcitabine Powder For Injection Historical Sales by Application (2016-2021)
5.1.2 Global Gemcitabine Powder For Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Gemcitabine Powder For Injection Sales Market Share by Application (2016-2027)
5.2 Global Gemcitabine Powder For Injection Revenue by Application
5.2.1 Global Gemcitabine Powder For Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Gemcitabine Powder For Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Gemcitabine Powder For Injection Revenue Market Share by Application (2016-2027)
5.3 Global Gemcitabine Powder For Injection Price by Application
5.3.1 Global Gemcitabine Powder For Injection Price by Application (2016-2021)
5.3.2 Global Gemcitabine Powder For Injection Price Forecast by Application (2022-2027)

6 North America
6.1 North America Gemcitabine Powder For Injection Market Size by Dosage Type
6.1.1 North America Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
6.1.2 North America Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
6.2 North America Gemcitabine Powder For Injection Market Size by Application
6.2.1 North America Gemcitabine Powder For Injection Sales by Application (2016-2027)
6.2.2 North America Gemcitabine Powder For Injection Revenue by Application (2016-2027)
6.3 North America Gemcitabine Powder For Injection Market Size by Country
6.3.1 North America Gemcitabine Powder For Injection Sales by Country (2016-2027)
6.3.2 North America Gemcitabine Powder For Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Gemcitabine Powder For Injection Market Size by Dosage Type
7.1.1 Europe Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
7.1.2 Europe Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
7.2 Europe Gemcitabine Powder For Injection Market Size by Application
7.2.1 Europe Gemcitabine Powder For Injection Sales by Application (2016-2027)
7.2.2 Europe Gemcitabine Powder For Injection Revenue by Application (2016-2027)
7.3 Europe Gemcitabine Powder For Injection Market Size by Country
7.3.1 Europe Gemcitabine Powder For Injection Sales by Country (2016-2027)
7.3.2 Europe Gemcitabine Powder For Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Gemcitabine Powder For Injection Market Size by Dosage Type
8.1.1 Asia Pacific Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
8.1.2 Asia Pacific Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
8.2 Asia Pacific Gemcitabine Powder For Injection Market Size by Application
8.2.1 Asia Pacific Gemcitabine Powder For Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Gemcitabine Powder For Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Gemcitabine Powder For Injection Market Size by Region
8.3.1 Asia Pacific Gemcitabine Powder For Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Gemcitabine Powder For Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Gemcitabine Powder For Injection Market Size by Dosage Type
9.1.1 Latin America Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
9.1.2 Latin America Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
9.2 Latin America Gemcitabine Powder For Injection Market Size by Application
9.2.1 Latin America Gemcitabine Powder For Injection Sales by Application (2016-2027)
9.2.2 Latin America Gemcitabine Powder For Injection Revenue by Application (2016-2027)
9.3 Latin America Gemcitabine Powder For Injection Market Size by Country
9.3.1 Latin America Gemcitabine Powder For Injection Sales by Country (2016-2027)
9.3.2 Latin America Gemcitabine Powder For Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Gemcitabine Powder For Injection Market Size by Dosage Type
10.1.1 Middle East and Africa Gemcitabine Powder For Injection Sales by Dosage Type (2016-2027)
10.1.2 Middle East and Africa Gemcitabine Powder For Injection Revenue by Dosage Type (2016-2027)
10.2 Middle East and Africa Gemcitabine Powder For Injection Market Size by Application
10.2.1 Middle East and Africa Gemcitabine Powder For Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Gemcitabine Powder For Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Gemcitabine Powder For Injection Market Size by Country
10.3.1 Middle East and Africa Gemcitabine Powder For Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Gemcitabine Powder For Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Accord Healthcare
11.1.1 Accord Healthcare Corporation Information
11.1.2 Accord Healthcare Overview
11.1.3 Accord Healthcare Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Accord Healthcare Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Accord Healthcare Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pfizer Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Overview
11.3.3 Eli Lilly and Company Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Eli Lilly and Company Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly and Company Recent Developments
11.4 DRUG INTERNATIONAL LTD
11.4.1 DRUG INTERNATIONAL LTD Corporation Information
11.4.2 DRUG INTERNATIONAL LTD Overview
11.4.3 DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 DRUG INTERNATIONAL LTD Recent Developments
11.5 Strides Pharma Science Limited
11.5.1 Strides Pharma Science Limited Corporation Information
11.5.2 Strides Pharma Science Limited Overview
11.5.3 Strides Pharma Science Limited Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Strides Pharma Science Limited Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Strides Pharma Science Limited Recent Developments
11.6 Getwell Pharmaceuticals
11.6.1 Getwell Pharmaceuticals Corporation Information
11.6.2 Getwell Pharmaceuticals Overview
11.6.3 Getwell Pharmaceuticals Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Getwell Pharmaceuticals Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Getwell Pharmaceuticals Recent Developments
11.7 Jiangsu Hansoh Pharmaceutical Group
11.7.1 Jiangsu Hansoh Pharmaceutical Group Corporation Information
11.7.2 Jiangsu Hansoh Pharmaceutical Group Overview
11.7.3 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
11.8 Harbin Pharmaceutical Group
11.8.1 Harbin Pharmaceutical Group Corporation Information
11.8.2 Harbin Pharmaceutical Group Overview
11.8.3 Harbin Pharmaceutical Group Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Harbin Pharmaceutical Group Gemcitabine Powder For Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Harbin Pharmaceutical Group Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Gemcitabine Powder For Injection Value Chain Analysis
12.2 Gemcitabine Powder For Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gemcitabine Powder For Injection Production Mode & Process
12.4 Gemcitabine Powder For Injection Sales and Marketing
12.4.1 Gemcitabine Powder For Injection Sales Channels
12.4.2 Gemcitabine Powder For Injection Distributors
12.5 Gemcitabine Powder For Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gemcitabine Powder For Injection Industry Trends
13.2 Gemcitabine Powder For Injection Market Drivers
13.3 Gemcitabine Powder For Injection Market Challenges
13.4 Gemcitabine Powder For Injection Market Restraints

14 Key Findings in The Global Gemcitabine Powder For Injection Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer